StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Hemogenyx Pharmaceuticals Plc
LSE:HEMO.L
Sector
Industries
Location
Market Cap
USD 9.43 M
Share Price
USD 1.91
Avg Daily Volume
31,506
Change (1 day)
-0.60%
Change (1 year)
11,194.37%
Change (YTD)
-62.38%
Hemogenyx Pharmaceuticals Plc EBITDA for the year ending December 31, 2024: USD -5.90 M
Hemogenyx Pharmaceuticals Plc EBITDA is USD -5.90 M for the year ending December 31, 2024, a -19.16% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
-
Hemogenyx Pharmaceuticals Plc EBITDA for the year ending December 31, 2023 was USD -7.30 M, a 76.38% change year over year.
-
Hemogenyx Pharmaceuticals Plc EBITDA for the year ending December 31, 2022 was USD -4.14 M, a 28.09% change year over year.
-
Hemogenyx Pharmaceuticals Plc EBITDA for the year ending December 31, 2021 was USD -3.23 M, a 20.97% change year over year.
-
Hemogenyx Pharmaceuticals Plc EBITDA for the year ending December 31, 2020 was USD -2.67 M, a 47.93% change year over year.
Competitors
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Novo Nordisk A/S
USD 69.36
NOVO-B.CO
+0.76
1.10%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
Novartis AG
USD 120.84
NOVN.SW
+0.06
0.05%
Abbott Laboratories
USD 132.03
ABT
+0.01
0.01%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Thermo Fisher Scientific Inc.
USD 425.34
TMO
-9.52
-2.19%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Boston Scientific Corporation
USD 104.33
BSX
+1.13
1.09%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Vertex Pharmaceuticals Incorporated
USD 472.35
VRTX
+3.50
0.75%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Bristol-Myers Squibb Company
USD 47.34
BMY
+0.48
1.02%
GSK plc
USD 19.13
GSK.L
+0.13
0.71%
CSL Limited
USD 163.16
CSL.AX
+5.04
3.19%
Chugai Pharmaceutical Co., Ltd.
USD 46.16
4519.T
-0.43
-0.92%
Regeneron Pharmaceuticals, Inc.
USD 570.59
REGN
+2.85
0.50%
Siemens Healthineers AG
USD 53.64
SHL.DE
-0.22
-0.40%
Key Data
| Date | EBITDA | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) |
|---|
Competitors
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Novo Nordisk A/S
USD 69.36
NOVO-B.CO
+0.76
1.10%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
Novartis AG
USD 120.84
NOVN.SW
+0.06
0.05%
Abbott Laboratories
USD 132.03
ABT
+0.01
0.01%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Thermo Fisher Scientific Inc.
USD 425.34
TMO
-9.52
-2.19%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Boston Scientific Corporation
USD 104.33
BSX
+1.13
1.09%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Vertex Pharmaceuticals Incorporated
USD 472.35
VRTX
+3.50
0.75%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Bristol-Myers Squibb Company
USD 47.34
BMY
+0.48
1.02%
GSK plc
USD 19.13
GSK.L
+0.13
0.71%
CSL Limited
USD 163.16
CSL.AX
+5.04
3.19%
Chugai Pharmaceutical Co., Ltd.
USD 46.16
4519.T
-0.43
-0.92%
Regeneron Pharmaceuticals, Inc.
USD 570.59
REGN
+2.85
0.50%
Siemens Healthineers AG
USD 53.64
SHL.DE
-0.22
-0.40%